Medical cannabis

Gilbert J. Fanciullo MD, MS

doi:10.5055/jom.2009.0026

Authors

Gilbert J. Fanciullo MD, MS

DOI:

https://doi.org/10.5055/jom.2009.0026

Keywords:

-

Author Biography

Gilbert J. Fanciullo MD, MS

Professor of Anesthesiology, Dartmouth Medical School; Director, Section of Pain Medicine, Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.

References

Aggarwal SK, Carter GT, Sullivan MD, et al.: Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. Journal of Opioid Management. 2009; 5(5): 257-286.

McCarberg BH, Barkin RL: The future of cannibinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamics overview. American Journal of Therapeutics. 2007; 14(5): 475-483.

Wilsey B, Marcotte T, Tsodikov A, et al.: A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. The Journal of Pain. 2008; 9(6): 506-521.

Ware MA, Doyle CR, Woods R, et al.: Cannabis use for chronic non-cancer pain: results of a prospective study. Pain. 2003; 102:211-216.

Delourme J, Delattre C, Godard P, et al.: [Respiratory consequences of inhalation of adulterated cannabis] [French]. Revue des Maladies Respiratories. 2009; 26(5): 552-556.

Reece AS: Chronic toxicology of cannabis. Clinical Toxicology. 2009; 47(6): 517-524.

Filbey FM, Schacht JP, Myers US, et al.: Marijuana craving in the brain. Proceedings of the National Academy of Science. 2009; 106(31): 13016-13021.

Cohen PJ: Medical marijuana: the conflict between scientific evidence and political ideology. The Journal of Pain & Palliative Pharmacotherapy. 2009; 23(1): 4-25.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain. 2009; 10(2): 113-130.